Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Babion I, Snoek BC, Novianti PW, Jaspers A, van Trommel N, Heideman DAM, Meijer CJLM, Snijders PJF, Steenbergen RDM, Wilting SM.

Clin Epigenetics. 2018 Jun 7;10:76. doi: 10.1186/s13148-018-0509-9. eCollection 2018.

2.

The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.

Bosschieter J, Lutz C, Segerink LI, Vis AN, Zwarthoff EC, A van Moorselaar RJ, van Rhijn BW, Heymans MW, Jansma EP, Steenbergen RD, Nieuwenhuijzen JA.

Epigenomics. 2018 May;10(5):673-687. doi: 10.2217/epi-2017-0156. Epub 2018 Apr 25.

PMID:
29692199
3.

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.

De Strooper LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, Snijders PJF, Meijer CJLM, Heideman DAM.

Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31539. [Epub ahead of print]

PMID:
29663363
4.

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJG, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM.

Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.

PMID:
29632006
5.

The effect of ART on cervical cancer precursor lesions.

de Vries HJC, Steenbergen RDM.

Lancet HIV. 2018 Jan;5(1):e6-e8. doi: 10.1016/S2352-3018(17)30189-3. Epub 2017 Oct 26. No abstract available.

6.

Molecular events leading to HPV-induced high grade neoplasia.

Wilting SM, Steenbergen RDM.

Papillomavirus Res. 2016 Dec;2:85-88. doi: 10.1016/j.pvr.2016.04.003. Epub 2016 Apr 12. Review.

7.

A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens.

Babion I, Snoek BC, van de Wiel MA, Wilting SM, Steenbergen RDM.

J Mol Diagn. 2017 Sep;19(5):625-637. doi: 10.1016/j.jmoldx.2017.04.010.

PMID:
28826607
8.

Selection of women at risk for cervical cancer in an HIV-infected South African population.

Van Zummeren M, Kremer WW, Van Aardt MC, Breytenbach E, Richter KL, Rozendaal L, Witte BI, De Strooper LMA, Hesselink AT, Heideman DAM, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583.

PMID:
28692545
9.

Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences.

Meijer CJLM, Steenbergen RDM.

Nat Rev Clin Oncol. 2017 Jul;14(7):397-398. doi: 10.1038/nrclinonc.2017.52. Epub 2017 Apr 11. No abstract available.

PMID:
28397825
10.

Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.

Khan S, Oosterhuis K, Wunderlich K, Bunnik EM, Bhaggoe M, Boedhoe S, Karia S, Steenbergen RDM, Bosch L, Serroyen J, Janssen S, Schuitemaker H, Vellinga J, Scheper G, Zahn R, Custers J.

Int J Cancer. 2017 Jul 15;141(2):393-404. doi: 10.1002/ijc.30679. Epub 2017 Apr 24.

11.

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.

Verlaat W, Snijders PJF, Novianti PW, Wilting SM, De Strooper LMA, Trooskens G, Vandersmissen J, Van Criekinge W, Wisman GBA, Meijer CJLM, Heideman DAM, Steenbergen RDM.

Clin Cancer Res. 2017 Jul 15;23(14):3813-3822. doi: 10.1158/1078-0432.CCR-16-2641. Epub 2017 Jan 24.

12.

High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.

Aromseree S, Middeldorp JM, Pientong C, van Eijndhoven M, Ramayanti O, Lougheed SM, Pegtel DM, Steenbergen RD, Ekalaksananan T.

PLoS One. 2017 Jan 5;12(1):e0169290. doi: 10.1371/journal.pone.0169290. eCollection 2017.

13.

Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.

Molano M, Moreno-Acosta P, Morales N, Burgos M, Buitrago L, Gamboa O, Alvarez R, Garland SM, Tabrizi SN, Steenbergen RD, Mejía JC.

Cancer Genomics Proteomics. 2016 11-12;13(6):483-491.

14.

Immortalization capacity of HPV types is inversely related to chromosomal instability.

Schütze DM, Krijgsman O, Snijders PJ, Ylstra B, Weischenfeldt J, Mardin BR, Stütz AM, Korbel JO, de Winter JP, Meijer CJ, Quint WG, Bosch L, Wilting SM, Steenbergen RD.

Oncotarget. 2016 Jun 21;7(25):37608-37621. doi: 10.18632/oncotarget.8058.

15.

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.

Wang R, van Leeuwen RW, Boers A, Klip HG, de Meyer T, Steenbergen RD, van Criekinge W, van der Zee AG, Schuuring E, Wisman GB.

Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.

16.

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.

Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ.

Int J Cancer. 2017 Jan 15;140(2):423-430. doi: 10.1002/ijc.30449. Epub 2016 Oct 11.

17.

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis.

Verlaat W, Snijders PJ, van Moorsel MI, Bleeker M, Rozendaal L, Sie D, Ylstra B, Meijer CJ, Steenbergen RD, Heideman DA.

J Pathol Clin Res. 2015 Sep 21;1(4):207-11. doi: 10.1002/cjp2.27. eCollection 2015 Oct.

18.

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.

Hubers AJ, Heideman DA, Duin S, Witte BI, de Koning HJ, Groen HJ, Prinsen CF, Bolijn AS, Wouters M, van der Meer SE, Steenbergen RD, Snijders PJ, Uyterlinde A, Berkhof H, Smit EF, Thunnissen E.

J Clin Pathol. 2017 Mar;70(3):250-254. doi: 10.1136/jclinpath-2016-203734. Epub 2016 Aug 5.

PMID:
27496969
19.

Management of high-risk HPV-positive women for detection of cervical (pre)cancer.

Luttmer R, De Strooper LM, Steenbergen RD, Berkhof J, Snijders PJ, Heideman DA, Meijer CJ.

Expert Rev Mol Diagn. 2016 Sep;16(9):961-74. doi: 10.1080/14737159.2016.1217157. Epub 2016 Aug 5. Review.

PMID:
27459506
20.

Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.

Uijterwaal MH, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM, Verheijen RHM, Helmerhorst TJM, van Dijken DKE, Spruijt JWM, van Kemenade FJ, Fransen-Daalmeijer N, Bekker-Lettink M, Heideman DAM, Snijders PJF, Steenbergen RDM, Meijer CJLM.

Gynecol Oncol. 2016 Oct;143(1):135-142. doi: 10.1016/j.ygyno.2016.07.089. Epub 2016 Jul 16.

PMID:
27430395
21.

Prevalence of Neovaginal High-Risk Human Papillomavirus Among Transgender Women in The Netherlands.

van der Sluis WB, Buncamper ME, Bouman MB, Elfering L, Özer M, Bogaarts M, Steenbergen RD, Heideman DA, Mullender MG.

Sex Transm Dis. 2016 Aug;43(8):503-5. doi: 10.1097/OLQ.0000000000000476.

PMID:
27414682
22.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.

Luttmer R, De Strooper LM, Dijkstra MG, Berkhof J, Snijders PJ, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ.

Br J Cancer. 2016 Aug 23;115(5):579-87. doi: 10.1038/bjc.2016.200. Epub 2016 Jul 14.

23.

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.

Wilting SM, Miok V, Jaspers A, Boon D, Sørgård H, Lando M, Snoek BC, van Wieringen WN, Meijer CJ, Lyng H, Snijders PJ, Steenbergen RD.

Oncotarget. 2016 Jul 12;7(28):43805-43819. doi: 10.18632/oncotarget.9698.

24.

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature.

van der Sluis WB, Buncamper ME, Bouman MB, Neefjes-Borst EA, Heideman DA, Steenbergen RD, Mullender MG.

Sex Transm Infect. 2016 Mar 24. pii: sextrans-2015-052456. doi: 10.1136/sextrans-2015-052456. [Epub ahead of print]

PMID:
27013740
25.

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.

De Strooper LMA, Verhoef VMJ, Berkhof J, Hesselink AT, de Bruin HME, van Kemenade FJ, Bosgraaf RP, Bekkers RLM, Massuger LFAG, Melchers WJG, Steenbergen RDM, Snijders PJF, Meijer CJLM, Heideman DAM.

Gynecol Oncol. 2016 May;141(2):341-347. doi: 10.1016/j.ygyno.2016.02.012. Epub 2016 Mar 3.

26.

Disc large 1 expression is altered by human papillomavirus E6/E7 proteins in organotypic cultures of human keratinocytes.

Valdano MB, Cavatorta AL, Morale MG, Marziali F, de Souza Lino V, Steenbergen RD, Boccardo E, Gardiol D.

J Gen Virol. 2016 Feb;97(2):453-62. doi: 10.1099/jgv.0.000364. Epub 2015 Dec 9.

PMID:
26653181
27.

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).

Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, Van Baal WM, Graziosi PG, Quint WG, Heideman DA, Meijer CJ.

Int J Cancer. 2016 Feb 15;138(4):992-1002. doi: 10.1002/ijc.29824. Epub 2015 Sep 14.

28.

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H.

Epigenetics. 2015;10(10):970-80. doi: 10.1080/15592294.2015.1085140.

29.

Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.

de Groen FL, Timmer LM, Menezes RX, Diosdado B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

PLoS One. 2015 Jul 6;10(7):e0132495. doi: 10.1371/journal.pone.0132495. eCollection 2015.

30.

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.

Hubers AJ, Heideman DA, Burgers SA, Herder GJ, Sterk PJ, Rhodius RJ, Smit HJ, Krouwels F, Welling A, Witte BI, Duin S, Koning R, Comans EF, Steenbergen RD, Postmus PE, Meijer GA, Snijders PJ, Smit EF, Thunnissen E.

Br J Cancer. 2015 Mar 17;112(6):1105-13. doi: 10.1038/bjc.2014.636.

31.

Mining for viral fragments in methylation enriched sequencing data.

Mensaert K, Van Criekinge W, Thas O, Schuuring E, Steenbergen RD, Wisman GB, De Meyer T.

Front Genet. 2015 Feb 4;6:16. doi: 10.3389/fgene.2015.00016. eCollection 2015.

32.

Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.

Verhoef VM, van Kemenade FJ, Rozendaal L, Heideman DA, Bosgraaf RP, Hesselink AT, Melchers WJ, Massuger LF, Bekkers RL, Steenbergen RD, Berkhof J, Snijders PJ, Meijer CJ.

Gynecol Oncol. 2015 Apr;137(1):55-9. doi: 10.1016/j.ygyno.2015.01.550. Epub 2015 Feb 8.

PMID:
25667975
33.

Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Schütze DM, Kooter JM, Wilting SM, Meijer CJ, Quint W, Snijders PJ, Steenbergen RD.

Epigenetics. 2015;10(1):73-81. doi: 10.4161/15592294.2014.990787. Epub 2015 Jan 23.

34.

Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.

Pinheiro C, Garcia EA, Morais-Santos F, Scapulatempo-Neto C, Mafra A, Steenbergen RD, Boccardo E, Villa LL, Baltazar F, Longatto-Filho A.

BMC Cancer. 2014 Oct 8;14:751. doi: 10.1186/1471-2407-14-751.

35.

CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.

De Strooper LM, van Zummeren M, Steenbergen RD, Bleeker MC, Hesselink AT, Wisman GB, Snijders PJ, Heideman DA, Meijer CJ.

J Clin Pathol. 2014 Dec;67(12):1067-71. doi: 10.1136/jclinpath-2014-202616. Epub 2014 Oct 3.

PMID:
25281766
36.

Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.

De Strooper LM, Meijer CJ, Berkhof J, Hesselink AT, Snijders PJ, Steenbergen RD, Heideman DA.

Cancer Prev Res (Phila). 2014 Dec;7(12):1251-7. doi: 10.1158/1940-6207.CAPR-14-0237. Epub 2014 Oct 3.

37.

tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities.

Miok V, Wilting SM, van de Wiel MA, Jaspers A, van Noort PI, Brakenhoff RH, Snijders PJ, Steenbergen RD, van Wieringen WN.

BMC Bioinformatics. 2014 Oct 2;15:327. doi: 10.1186/1471-2105-15-327.

38.

Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.

Snellenberg S, Cillessen SA, Van Criekinge W, Bosch L, Meijer CJ, Snijders PJ, Steenbergen RD.

Carcinogenesis. 2014 Nov;35(11):2611-8. doi: 10.1093/carcin/bgu197. Epub 2014 Sep 18.

PMID:
25233927
39.

HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.

Rodríguez-Carunchio L, Soveral I, Steenbergen RD, Torné A, Martinez S, Fusté P, Pahisa J, Marimon L, Ordi J, del Pino M.

BJOG. 2015 Jan;122(1):119-27. doi: 10.1111/1471-0528.13071. Epub 2014 Sep 17.

40.

Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.

Verhoef VM, Heideman DA, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, Bekkers RL, Massuger LF, Steenbergen RD, Snijders PJ, Berkhof J, Meijer CJ.

Gynecol Oncol. 2014 Oct;135(1):58-63. doi: 10.1016/j.ygyno.2014.08.003. Epub 2014 Aug 8.

PMID:
25111387
41.

Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack.

Krijgsman O, Carvalho B, Meijer GA, Steenbergen RD, Ylstra B.

Biochim Biophys Acta. 2014 Nov;1843(11):2698-2704. doi: 10.1016/j.bbamcr.2014.08.001. Epub 2014 Aug 7. Review.

42.

Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.

De Strooper LM, Hesselink AT, Berkhof J, Meijer CJ, Snijders PJ, Steenbergen RD, Heideman DA.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1933-7. doi: 10.1158/1055-9965.EPI-14-0347. Epub 2014 Jun 24.

43.

Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.

Hubers AJ, Brinkman P, Boksem RJ, Rhodius RJ, Witte BI, Zwinderman AH, Heideman DA, Duin S, Koning R, Steenbergen RD, Snijders PJ, Smit EF, Sterk PJ, Thunnissen E.

J Clin Pathol. 2014 Aug;67(8):707-11. doi: 10.1136/jclinpath-2014-202414. Epub 2014 Jun 10.

PMID:
24915850
44.

Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.

Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ.

Nat Rev Cancer. 2014 Jun;14(6):395-405. doi: 10.1038/nrc3728. Review.

PMID:
24854082
45.

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial.

Verhoef VM, Bosgraaf RP, van Kemenade FJ, Rozendaal L, Heideman DA, Hesselink AT, Bekkers RL, Steenbergen RD, Massuger LF, Melchers WJ, Bulten J, Overbeek LI, Berkhof J, Snijders PJ, Meijer CJ.

Lancet Oncol. 2014 Mar;15(3):315-22. doi: 10.1016/S1470-2045(14)70019-1. Epub 2014 Feb 13.

PMID:
24529697
46.

Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.

de Groen FL, Krijgsman O, Tijssen M, Vriend LE, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

Genes Chromosomes Cancer. 2014 Apr;53(4):339-48. doi: 10.1002/gcc.22144. Epub 2014 Jan 29.

PMID:
24478024
47.

Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.

Hesselink AT, Heideman DA, Steenbergen RD, Gök M, van Kemenade FJ, Wilting SM, Berkhof J, Meijer CJ, Snijders PJ.

Int J Cancer. 2014 Aug 15;135(4):880-6. doi: 10.1002/ijc.28723. Epub 2014 Jan 28.

48.

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.

Voorham QJ, Janssen J, Tijssen M, Snellenberg S, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken BJ, Mulder CJ, van Engeland M, Meijer GA, Steenbergen RD, Carvalho B.

BMC Cancer. 2013 Dec 19;13:603. doi: 10.1186/1471-2407-13-603.

49.

Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Schütze DM, Snijders PJ, Bosch L, Kramer D, Meijer CJ, Steenbergen RD.

J Virol. 2014 Feb;88(3):1714-24. doi: 10.1128/JVI.02859-13. Epub 2013 Nov 20. Erratum in: J Virol. 2014 May;88(9):5205.

50.

Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.

Steenbergen RD, Ongenaert M, Snellenberg S, Trooskens G, van der Meide WF, Pandey D, Bloushtain-Qimron N, Polyak K, Meijer CJ, Snijders PJ, Van Criekinge W.

J Pathol. 2013 Sep;231(1):53-62. doi: 10.1002/path.4210. Epub 2013 Jul 8.

PMID:
23674368

Supplemental Content

Loading ...
Support Center